BACKGROUND: Patients undergoing a transfer during a hospitalization may be more likely to be diagnosed with a venous thromboembolism (VTE) than patients who are not transferred. OBJECTIVE: To determine whether transferred patients have an increased prevalence of VTE diagnosis. DESIGN: This was a cross-sectional study comparing VTE diagnosis rates between transferred patients and non-transferred patients. For the years 2012-2014, the University HealthSystem Consortium database of multiple community and academic medical centers throughout the United States was parsed using ICD-9 VTE diagnosis codes and patient's point of origin. PATIENTS: Patients were included in the analysis as transferred patients if their point of origin was a skilled nursing facility, another acute care facility or another facility. Nontransferred patients were those whose point of origin was a clinic or those with a non-facility point of origin. MAIN MEASURES: The primary comparison of VTE prevalence during hospitalization between transferred and non-transferred patients in the years 2012-2014. Subgroup analysis looked at level I trauma status and case mix index (CMI) to determine whether these had an effect on VTE prevalence. KEY RESULTS: From 2012 to 2014, a total of 225 unique hospitals and 12,036,029 patients were analyzed, and the prevalence of VTE in transferred patients and nontransferred patients was 3.43% and 1.91% (RR 1.80; 95% CI 1.78-1.81; P <0.001), respectively. VTE prevalence in transferred versus non-transferred patients at level I trauma centers was 3.42% versus 1.88% (RR = 1.82; 95% CI 1.80-1.85; P <0.001). The 3-year average CMI of transferred versus non-transferred patients was 3.53 versus 2.26 (P < 0.001). CONCLUSIONS: Transferred patients have a higher prevalence of VTE than non-transferred patients, regardless of level I trauma designation. Higher VTE rates in transferred versus non-transferred patients was minimally correlated with CMI.
INTRODUCTION
Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is an increasing cause of morbidity, mortality and economic burden in the United States, 1 with 60,000-300,000 deaths per year in the United States attributed to VTE. [2] [3] [4] Many risk factors for VTE have been studied, including a multitude of inherited and acquired traits. Hospitalization is a risk factor that likely reflects a patient's immobilization and illness severity. 5 Among hospitalized patients, transferred patients have been shown to have higher rates of mortality, likely due to their higher levels of acuity and severity of illness. 6, 7 In our institution, the University of California, Irvine Medical Center, we have observed a trend of increasing rates of VTE in patients transferred from outside hospitals. Indeed, a retrospective analysis over a 1-year period showed significantly increased rates of VTE in both surgical and non-surgical patients who had been transferred from an outside hospital. 8 The purpose of this study is thus to determine whether the increased incidence of VTE in patients transferred during hospitalization is unique to our institution, or whether this is a national trend. We hypothesize that, similar to the results observed in our internal investigation, transferred patients will have a higher prevalence of VTE than non-transferred patients on a national scale.
METHODS

Cross-Sectional Study
Data were obtained from the University HealthSystem Consortium (UHC) Clinical Database (CDB), which pools data from more than 95% of the non-profit academic medical centers and affiliated teaching and specialty hospitals in the United States. The CDB allows for rapid search and retrieval of healthrelated metrics from all member hospitals at a population level.
Study Population
The CDB allows for categorization of patients based on multiple criteria but we focused on admission source, VTE ICD-9 coding, age, length of stay and years of interest. We applied these criteria to two groups of patients, one of which we labeled Bnon-transferred patients^and the other Btransferred patients.^Admission source criteria for non-transferred patients were Bclinical referral^or Bnon-facility point of origin,ŵ ith the latter including patients admitted from home or an out-of-system clinic. For transferred patients, admission source criteria were defined as Btransfer from a different hospital,^Btransfer from another facility,^or Btransfer from skilled nursing facility.^BAnother facility^is defined here as patients arriving from long-term acute care, acute rehab units or inpatient psychiatry facilities.
Utilizing these criteria, we were able to identify patients who at any point during their hospitalization were transferred to another hospital. Both transferred and non-transferred patients were then queried for ICD-9 codes for VTE (see Appendix A), and the criteria were narrowed to those between the ages of 18 and 100 years and a length of stay of 0 to 120 days.
Then, given the paucity of data in the database before 2012, we chose to look at the years 2012-2014. This analysis yielded 225 unique hospitals and 12,036,029 patients, among which 1,445,786 met the aforementioned definition of Btransferred,^with the remaining 10,593,734 classified as Bnon-transferred^(see Appendix Table 3 ).
Study Measures
The primary analysis compared the prevalence of VTE between transferred and non-transferred patients. Secondary analyses examined the differences in prevalence between transferred and non-transferred patient groups stratified by (1) level I trauma center status and (2) patient case mix index (CMI). We chose level I trauma center status because of our hypothesis that transferred patients would be likely to have a longer duration of immobility and higher illness severity. Level I trauma centers generally have a higher average rate of transfers, given their nature as the highest-accepting resource for health facilities in nearby regions. 9, 10 We utilized the CMI as a surrogate tool to estimate severity of illness and disease complexity for transferred and non-transferred patient groups. We hypothesized that the higher rate of VTE diagnosis in our transferred patient population was due, in part, to greater disease complexity and illness severity. The CMI is calculated by averaging the Medicare Severity Diagnosis Related Groups (MS-DRG) weight of the selected patients discharged within the period of interest. 11 The data were further stratified into six CMI segments within level I trauma centers and non-level I trauma centers, for a total of 12 groups for each year.
We compared the proportion of patients with VTE in the transferred and non-transferred groups using a chi-square test. The ratio of these proportions was calculated and a 95% confidence interval surrounding this relative risk was generated assuming a normal distribution. This was repeated with stratification for trauma center status and for the sextile of the CMI. Calculations were completed using Microsoft Excel ® 2016 (version 1609).
RESULTS
Primary Analysis
While the total prevalence averaged 2.09% over 3 years, the prevalence of VTE was 3.43% in transferred patients versus 1.91% in non-transferred patients (RR 1.80; 95% CI 1.78-1.81; P = <0.001). (Table 1) . Overall, transferred patients accounted for approximately 10-13% of total hospitalized patients and were associated with roughly 20% of all VTE in each of the 3 years studied (See Appendix Tables 3 and 4) .
Level I Trauma Center Subgroup Analysis
From 2012 to 2014, patients transferred to level I trauma centers averaged 13.4% of total admissions, whereas transfers accounted for an average of 10.6% of total admissions at nonlevel I trauma centers. VTE prevalence in transferred versus non-transferred patients at level I trauma centers was 3.42% versus 1.88% (RR = 1.82; 95% CI, 1.80-1.85; P < .001). The respective VTE prevalence rates were 3.43% and 1.94% (RR = 1.77; 95% CI, 1.74-1.79; P < .001) at non-level I trauma centers (Table 2) .
Case Mix Index Subgroup Analysis
The increased rate for VTE in transferred patients remained statistically significant when all selected hospitals were stratified by CMI, with the exception of the bottom sextile in 2014 ( Fig. 1) . At level I trauma centers, there was a statistically significant increase in the rate of VTE in transferred patients at all levels of CMI (Fig. 2) . Non-level I trauma centers in the bottom sextile of CMI had no increase in VTE rate in transferred patients for years included in the search (Fig. 3) .
Lastly, the CMI in transferred versus non-transferred patients with VTE for the total 3-year period was 3.53 versus 2.26, which was statistically significant (p < 0.001; see Appendix Table 6 ).
DISCUSSION
To our knowledge, this is the first study analyzing a patient's transfer status and its relation to VTE prevalence. Based on the above results from 3 different years and in different types of hospitals throughout the United States, this cross-sectional study reveals a higher prevalence of VTE in transferred patients. In our secondary analyses comparing transferred and non-transferred patients, we found a very small statistical difference in VTE rates between level I trauma and non-level I trauma centers. This extremely small difference implies that level I trauma status is not significantly associated with VTE prevalence. Lastly, as CMI increases from the sixth to first sextile, there is a statistically significant correlation with the relative risk of VTE in both transferred and non-transferred patients during the years 2013-2014, which likely reflects the increased acuity and illness severity of transferred patients.
The higher rate of VTE in transferred patients is likely due to increased immobilization and illness severity. As described by Clough et al., transferred patients generally have higher rates of morbidity or mortality, regardless of the reason for their transfer, due to increased illness severity. 6 Our secondary analyses of CMI supports this idea by describing a statistically significant difference between the CMI of transferred and nontransferred patients over the period 2012-2014 (Appendix Tables 5 and 6 and Figs. 2, 3, 4, 5 and 6 ). In addition, these patients also likely have higher rates of immobility. As Golestanian et al. and Rosenberg et al. have shown, transferred patients have longer lengths of stay, which likely contributes to higher rates of immobility and VTE incidence. 10, 12 As shown in Table 2 , level I trauma status had a very small, statistically significant effect on VTE prevalence when comparing transferred versus non-transferred patients. One possible explanation for the very small difference is that all hospitals have comparable adherence to VTE prevention guidelines. A wide range of studies have shown that hospital utilization of VTE prevention protocols and adherence to society guidelines is suboptimal. In 2007, Amin et al. showed that among all acute medical inpatients considered at high risk for VTE prophylaxis, as defined by the sixth edition of the American College of Chest Physicians (ACCP) guidelines for VTE prevention, only 40% received adequate prophylaxis. 13 Similarly, the VTE START [venous thromboembolism study to assess the rate of thromboprophylaxis], conducted by Amin et al. in 2010 to assess the adequacy of the type, duration and dose of VTE prophylaxis, revealed low adherence levels of 12.7% and 16.4% for medical and surgical patients, respectively.
14 Importantly, our data show that transferred patients accounted for a disproportionate share of VTE during the study period. Transferred patients constituted 12.0% of total hospitalized patients, yet accounted for 19.9% of VTE diagnoses. This raises three concerns that can be extrapolated from our data into the broader range of health care policy: 1) If a VTE is diagnosed as a hospital-acquired condition, then which hospital should incur the VTE diagnosis penalty, the transferring or accepting hospital? 2) How can transferring hospitals be encouraged to improve guideline adherence? 3) Should there be special VTE screening protocols for transferred patients?
The Centers for Medicare & Medicaid Services (CMS) and The Joint Commission have developed performance measures that affect Medicare reimbursement. As an example, Patient Safety Indicator #12 (PSI-12) assesses perioperative VTE rates via ICD coding. 15 In addition, since 2007, CMS has required that discharge diagnoses be labeled as Bpresent on admissionô r Bnot present on admission^in order to accurately determine penalties and payments. 16, 17 Those noted to be in the lowest quartile of quality measures will see a reduction in Medicare reimbursements. In order for a condition to be qualified as present on admission, the accepting center physician must document either that they suspect that it is present, that the condition is pre-existing, or that the patient underwent treatment for the condition. 18 However, as reported by Usher et al., a common problem in handoffs between hospitals is that the documentation in the transfer packet sent to the accepting hospital is incomplete. 19 A large systematic review by Ong et al. in 2011 also showed a significant breakdown in communication between transferring and accepting hospitals, leading to poor patient outcomes. 20 With documentation frequently incomplete on arrival, accurate coding of present-on-admission conditions is difficult. Additional research on inter-hospital communication could greatly improve diagnosis, treatment and precise reporting to Medicare of preventable hospital conditions.
Since transferred patients have a higher rate of VTE diagnosis, there may be some benefit in screening tests to increase early VTE detection and prevention of PE or mortality. Screening venous duplex ultrasound has been studied in other high-risk populations, such as high-risk trauma or orthopedic surgery patients. For example, in 2016, Casey et al. showed that screening high-risk trauma patients for VTE with venous duplex ultrasound reduced their risk of PE, which the authors hypothesized was due to earlier detection and treatment of asymptomatic DVT. However, the ACCP guidelines recommend against screening ultrasound for DVT in all but a very select group of high-risk trauma patients with suboptimal or no thromboprophylaxis. 21 The results of this study suggest that perhaps there is a subset of transferred patients that would benefit from some type of screening. Further research is needed to provide a cost-benefit analysis of such screening methods. In addition to the uncertainty regarding the optimal screening mechanisms and patient population, hospitals are penalized for diagnosing hospital-acquired conditions. In a 2013 study, Bilimoria et al. reported that increased screening of patients to ensure compliance with Medicare quality measures was associated with a rise in the rates of reported VTE. 22 If increased compliance with Medicare quality measures is going to continue to be linked to reimbursement, policy discussions are needed to determine the need for screening and its interplay with penalties.
Lastly, as discussed above, adherence to VTE prevention guidelines is subpar in many hospitals. If reimbursement rates and Medicare penalties are associated in part with VTE prevention, then further steps need to be taken to improve compliance. There are various methods known to improve adherence. For example, in 2014, Khoury et al. demonstrated 99% adherence to VTE prophylaxis through the use of a computer-based clinical decision-making system. 23 However, the failure of physicians to appreciate the benefits of recommended therapy and the lack of adequate physician education about such guidelines 24,25 may contribute to the continued low rates of adherence. Regardless of the reason, stronger policies, procedures and incentives are needed in order to improve hospital adherence to prevention guidelines and to reduce the downstream effects of non-adherence.
LIMITATIONS
Our study has some limitations: (1) the UHC is a data-driven tool that depends on accurate coding; (2) data are obtained at a population level and not an individual level; (3) it is not possible to control for other known VTE risk factors.
As the CDB primarily comprises administrative billing data for coded patients, coding errors may have resulted in the inappropriate inclusion or exclusion of patients, although these errors likely affected both transferred and non-transferred patients equally. In addition, because information was gathered from a multi-hospital national database, individual-level data could not be obtained, and thus regression analyses could not be performed. Population-level statistics is the only tool at the UHC's disposal; however, this was adequate for the purposes of our study. As future studies are implemented, individual-level data can be gathered to assess and control for known VTE risk factors.
CONCLUSION
To the best of our knowledge, this is the first study to investigate whether transfer status is associated with VTE diagnosis. Our study shows that the rate of VTE diagnosis is higher in transferred patients than non-transferred patients across all types of hospitals in the United States.
Corresponding Author: Alpesh Amin, MD, MBA; University of C a l i f o r n i a , I r v i n e M e d i c a l C e n t e r, O r a n g e , C A , U S A (e-mail: ANAmin@uci.edu). Pearson's correlation coefficient r quantifies the degree of correlation between two values. In this case, we looked at increasing CMI in relation to increasing VTE relative risk. APPENDIX F
APPENDIX B
